Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation.
Wojciech G LesniakSrikanth BoinapallyGabriela LoflandZirui JiangCatherine A FossBabak Behman AzadAnna JablonskaMauro A GarciaMaria BrzezinskiMartin G PomperPublished in: International journal of nanomedicine (2024)
tumors. This approach holds promise for enhancing image-guided treatment of aggressive, metastatic subtypes of prostate cancer.